(R)-5-(HYDROXYMETHYL)-3-(4-IODOPHENYL)OXAZOLIDIN-2-ONE, 95.0%, 500mg

(5-Methyloxazol-2-yl)methanaminehydrochloride, 97%, 1g

1,3-Divinyl-1,3-diphenyl-1,3-dimethyldisiloxane, 95%, 5g

3-Bromo-6-iodo-o-xylene, 95+%, 25g

(S)-1-N-Boc-3-Hydroxypiperidine, 98.0%, 10g

2-Methyloctahydropyrrolo[3,4-c]pyrrole dihydrochloride, 95.0%, 1g

Accessories exchange block for reaction vessels, Gesch. for, 24 reaction vials 0.5 and 1.5 ml (combi block), 1 piece

Single-channel microliter pipette Pipetman® G, 0.2 to 2 µl, P2G, 1 piece

Isopropyl-methyl-(S)-pyrrolidin-3-yl-amine, 250mg

methyl N-[(2S)-1-[(6S)-6-[4-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptan-5-yl]-3-methyl-1-oxobutan-2-yl]carbamate, 98%, 500mg

Methyl 3-Aminopyrazine-2-carboxylate>98.0%(GC)(T)1g

6-Chloro-imidazo[1,2-a]pyridine-2-carboxylic acid, 98.0%, 10g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)acetanilide, 95.0%, 25g